4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-060778
Options or other derivatives
- General Counsel and Secretary acquired 10,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. General Counsel and Secretary | 2021-10-15 | Grant or award · Stock Option (Right to Buy) | +10,800 | 10,800 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…